Insight
Developing and Patenting AI Inventions: 5 Things for Biotech Companies to Consider
by Richard F. Martinelli, David Sharrow and Daniela Glaser
5 minute read | October.10.2024

by Richard F. Martinelli, David Sharrow and Daniela Glaser
5 minute read | October.10.2024
28 minute read | October.07.2024
by Amy M. Joseph, Jeremy D. Sherer, Emily Brodkin and Melania Jankowski
3 minute read | October.03.2024
The health care industry has used AI for decades, but the rise of generative AI raises questions about how to regulate the technology.
by Stephen Thau and Mike O'Donnell
3 minute read | September.26.2024
by Thora Johnson, Alyssa Wolfington, Amy M. Joseph, Jeremy D. Sherer, Emily Brodkin and Melania Jankowski
3 minute read | September.24.2024
by Stephen Thau and David Sharrow
4 minute read | September.23.2024
by Jeremy D. Sherer
1 minute read | September.23.2024
Proposed AI legislation in California may have big implications in health care.
by Thora Johnson, Amy M. Joseph and Georgia C. Ravitz
1 minute read | September.20.2024
by Julia Apostle, Daniel Kadin and David Sharrow
4 minute read | September.13.2024
EU AI Act is a landmark piece of legislation that establishes the first comprehensive framework for regulating the use of artificial intelligence.
by Amy Walsh
6 minute read | September.04.2024
What should public life sciences companies should know about expansive new theories of liability in two insider trading cases?
by Amy M. Joseph and Jeremy D. Sherer
5 minute read | September.04.2024
by Amy M. Joseph and Jeremy D. Sherer
7 minute read | August.15.2024
Federal agencies and lawmakers in several states are attempting to rewrite the rulebook for private investment in health care in the U.S.